Skip to content

CDR

NACDS adds government affairs execs

The National Association of Chain Drug Stores has made a pair of new appointments to its government affairs team. Joining NACDS are Julie Philp as director of federal government affairs and Joel Kurzman as a director of state government affairs.

Health Mart, MSI impress <i>Consumer Reports</i>

Health Mart and Medicine Shoppe International Inc. (MSI) have tied for second in Consumer Reports’ latest ranking of the best pharmacies. While independent drug stores took the top spot with a score of 93, Health Mart and MSI were each just one point behind.

An exceptional Annual Meeting unfolds

for a variety of reasons not connected to the program or the current issues facing the association or the chain drug industry. More ­specifically: • The 2011 NACDS Annual Meeting marks the last

National and store brands learn how to coexist

Even before the current recession, consumers began to put pressure on national brand manufacturers by positioning store brand products as the value alternative to branded products. It is well documented that consumers are now more accepting of less expensive quality alternatives to national brands.

Survey: Disconnect between migraine patients, doctors

A national survey released by the National Headache Foundation (NHF) and GlaxoSmithKline (GSK) revealed disparities between what migraine headache sufferers and physicians say they discuss during office visits, including their prescription medications and over-the-counter drugs.

Rite Aid cuts price of whooping cough shots in Calif.

More than 500 Rite Aid pharmacies in California are offering whooping cough vaccinations for a newly lowered price of $57.99. Rite Aid Corp. said Thursday that by July 1 — when a new California law takes effect requiring proof of pertussis immunization for all students entering grades 7 through 12 —

Salix granted patents for Xifaxan

Salix Pharmaceuticals Ltd. has been issued three patents for Xifaxan (rifaximin), an antibiotic for the intestinal tract, from the U.S. Patent and Trademark Office. The company said Wednesday that one of the patents (U.S. Patent No.

Mylan launches generic version of Famvir

Mylan Inc. has begun shipping famciclovir tablets, a treatment for herpes. The company said Wednesday that its Mylan Pharmaceuticals Inc. subsidiary is introducing famciclovir tablets in strengths of 125 mg, 250 mg and 500 mg.